Cholinesterase inhibitors for delirium: What is the evidence?

International Psychogeriatrics

Volumn 20, Issue 2, 2008, Pages 209-218

  Mukadam, N ^a   Ritchie, C W ^b   Sampson, E L ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE; NICOTINE; PLACEBO; PROCYCLIDINE; RIVASTIGMINE; SCOPOLAMINE;

BRAIN REGION; CLINICAL TRIAL; COGNITIVE DEFECT; DELIRIUM; DISEASE ASSOCIATION; EDITORIAL; ELECTROENCEPHALOGRAPHY; GABAERGIC SYSTEM; HUMAN; INCIDENCE; NEUROTRANSMISSION; NONHUMAN; RISK FACTOR; SEROTONINERGIC SYSTEM;

ACETYLCHOLINE; DELIRIUM; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES;

EID: 38949182992     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610207006205     Document Type: Editorial

References (53)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: American Psychiatric Association.
2. Ballard, C. G. et al. (2002). Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. Consciousness and Cognition, 11, 461-474.
3. Cole, M. G. and Primeau, F. J. (1993). Prognosis of delirium in elderly hospital patients. Canadian Medical Association Journal, 149, 41-46.
4. Cole, M. G., Primeau, F. and McCusker, J. (1996). Effectiveness of interventions to prevent delirium in hospitalized patients: a systematic review. Canadian Medical Association Journal, 155, 1263-1268.
5. Doyle, M. and Warden, D. (1996). Use of SPECT to evaluate postcardiotomy delirium. American Journal of Psychiatry, 153, 838-839.
6. Drachman, D. A. and Leavitt, J. (1974). Human memory and the cholinergic system. A relationship to aging? Archives of Neurology, 30, 113-121.
7. Dunne, M. P. and Hartley, L. R. (1986). Scopolamine and the control of attention in humans. Psychopharmacology (Berlin), 89, 94-97.
8. Elie,M., Cole,M.G., Primeau, F. J. and Bellavance, F. (1998). Delirium risk factors in elderly hospitalized patients. Journal of General Internal Medicine, 13, 204-212.
9. Gaudreau, J. D. and Gagnon, P. (2005). Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Medical Hypotheses, 64, 471-475.
10. Hagan, J. J., Salamone, J. D., Simpson, J., Iversen, S. D. and Morris, R. G. (1988). Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behavioural Brain Research, 27, 9-20.
11. Inouye, S. K. (1994). The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. American Journal of Medicine, 97, 278-288.
12. Inouye, S. K., Rushing, J. T., Foreman, M. D., Palmer, R. M. and Pompei, P. (1998). Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. Journal of General Internal Medicine, 13, 234-242.
13. Jacobson, S. and Jerrier, H. (2000). EEG in delirium. Seminars in Clinical Neuropsychiatry, 5, 86-92.
14. Koller, G. et al. (2003). Effects of scopolamine on matching to sample paradigm and related tests in human subjects. Neuropsychobiology, 48, 87-94.
15. Liptzin, B., Laki, A., Garb, J. L., Fingeroth, R. and Krushell, R. (2005). Donepezil in the prevention and treatment of post-surgical delirium. American Journal of Geriatric Psychiatry, 13, 1100-1106.
16. Mansvelder, H. D., van Aerde, K. I., Couey, J. J. and Brussaard, A. B. (2005). Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berlin), 184, 292-305.
17. McCusker, J., Cole, M., Dendukuri, N., Han, L. and Belzile, E. (2003). The course of delirium in older medical inpatients: a prospective study. Journal of General Internal Medicine, 18, 696-704.
18. McKeith, I. et al. (2000). Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. The Lancet, 356, 2031-2036.
19. Meagher, D. J. (2001). Delirium: optimising management. BMJ, 322, 144-149.
20. Meagher, D. J. et al. (2007). Phenomenology of delirium. British Journal of Psychiatry, 190, 135-141.
21. Mintzer, J. and Burns, A. (2000). Anticholinergic side-effects of drugs in elderly people. Journal of the Royal Society of Medicine, 93, 457-462.
22. Muir, J. L. (1996). Attention and stimulus processing in the rat. Cognitive Brain Research, 3, 215-225.
23. Muir, J. L. (1997). Acetylcholine, aging, and Alzheimer's disease. Pharmacology Biochemistry and Behaviour, 56, 687-696.
24. Naughton, B. J., Saltzman, S., Ramadan, F., Chadha, N., Priore, R. and Mylotte, J. M. (2005). A multifactorial intervention to reduce prevalence of delirium and shorten hospital length of stay. Journal of the American Geriatrics Society, 53, 18-23.
25. Noyan, M. A., Elbi, H. and Aksu, H. (2003). Donepezil for anticholinergic drug intoxication: a case report. Progress in Neuropsychopharmacology and Biological Psychiatry, 27, 885-887.
26. O'Keeffe, S. T. (1999). Clinical subtypes of delirium in the elderly. Dementia and Geriatric Cognitive Disorders, 10, 380-385.
27. Paton, C. (2002). Benzodiazepines and disinhibition: a review. Psychiatric Bulletin, 26, 460-462.
28. Perry, E. K. and Perry, R. H. (1995). Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition, 28, 240-258.
29. Perry, E. K., Perry, R. H., Blessed, G. and Tomlinson, B. E. (1978). Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathology and Applied Neurobiology, 4, 273-277.
30. Perry, E. K. et al. (1994). Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport, 5, 747-749.
31. Perry, E., Walker, M., Grace, J. and Perry, R. (1999). Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends in Neurosciences, 22, 273-280.
32. Reischies, F. M., Neuhaus, A. H., Hansen, M. L., Mientus, S., Mullert, C. and Gallinat, J. (2005). Electrophysiological and neuropsychological analysis of a delirious state: the role of the anterior cingulate gyrus. Psychiatry Research, 138, 171-181.
33. Ritchie, C. W., Ames, D., Clayton, T. and Lai, R. (2004). Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine and rivastigmine for the treatment of Alzheimer's disease. American Journal of Geriatric Psychiatry, 12, 358-369.
34. Rockwood, K. et al. (1994). Increasing the recognition of delirium in elderly patients. Journal of the American Geriatrics Society, 42, 252-256.
35. Rockwood, K., Cosway, S., Carver, D., Jarrett, P. and Stadnyk, K. (1999). The risk of dementia and death after delirium. Age and Ageing, 28, 551-556.
36. Rovner, B. W., David, A., Lucas-Blaustein, M. J., Conklin, B., Filipp, L. and Tune, L. (1988). Self-care capacity and anticholinergic drug levels in nursing home patients. American Journal of Psychiatry, 145, 107-109.
37. Sampson, E. L. et al. (2007). A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. International Journal of Geriatric Psychiatry, 22, 343-349.
38. Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934-1943.
39. Schneider, L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525-1538.
40. Schor, J. D. et al. (1992). Risk factors for delirium in hospitalized elderly. JAMA, 267, 827-831.
41. Seto, D., Zheng, W. H., McNicoll, A., Collier, B., Quirion, R. and Kar, S. (2002). Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience, 115, 603-612.
42. Shepherd, G. M. (1994). Neurobiology. 3rd edn. New York: Oxford University Press.
43. Slatkin, N. and Rhiner, M. (2004). Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report. Journal of Pain and Symptom Management, 27, 268-273.
44. Suh, G. H. and Shah, A. (2005). Effect of antipsychotics on mortality in elderly patients with dementia: a 1 year prospective study in a nursing home. International Psychogeriatrics, 17, 429-441.
45. Trzepacz, P. T., Mulsant, B. H., Amanda, D. M., Pasternak, R., Sweet, R. A. and Zubenko, G. S. (1998). Is delirium different when it occurs in dementia? A study using the delirium rating scale. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 199-204.
46. Tune, L. and Coyle, J. T. (1980). Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Archives of General Psychiatry, 37, 293-297.
47. Tune, L. E. and Egeli, S. (1999). Acetylcholine and delirium. Dementia and Geriatric Cognitive Disorders, 10, 342-344.
48. Tune, L. E., Damlouji, N. F., Holland, A., Gardner, T. J., Folstein, M. F. and Coyle, J. T. (1981). Association of postoperative delirium with raised serum levels of anticholinergic drugs. The Lancet, 2, 651-653.
49. Tune, L. et al. (1991). Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography. Acta Psychiatrica Scandinavica, 366 (Suppl.), 61-65.
50. Tune, L., Carr, S., Hoag, E. and Cooper, T. (1992). Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. American Journal of Psychiatry, 149, 1393-1394.
51. Warburton, D. M. and Rusted, J. M. (1993). Cholinergic control of cognitive resources. Neuropsychobiology, 28, 43-46.
52. World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization.
53. Zajicek, K. B., Higley, J. D., Suomi, S. J. and Linnoila, M. (1997). Rhesus macaques with high CSF 5-HIAA concentrations exhibit early sleep onset. Psychiatry Research, 73, 15-25.